Pelvic exenteration represents one of the most radical surgical interventions in oncological practice, aimed at achieving complete tumour clearance in locally advanced or recurrent pelvic malignancies ...
Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE). Background: This prospective study comprehensively examined quality of life (QOL) after ...
Interim analysis of a single-arm, phase II study of bevacizumab (BV) with modified OPTIMOX1 as first-line treatment of patients with metastatic colorectal cancer (mCRC): TCOG-GI0802. Outcomes of ...